Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3017948, 10 pages
https://doi.org/10.1155/2017/3017948
Research Article

Joint Covariate Detection on Expression Profiles for Selecting Prognostic miRNAs in Glioblastoma

College of Information and Computer Engineering, Northeast Forestry University, Harbin 150001, China

Correspondence should be addressed to Xudong Zhao; nc.ude.ufen@gnoduxoahz

Received 4 October 2016; Revised 18 January 2017; Accepted 27 February 2017; Published 20 March 2017

Academic Editor: Xia Li

Copyright © 2017 Chengqi Sun and Xudong Zhao. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. M. Gravendeel, M. C. M. Kouwenhoven, O. Gevaert et al., “Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology,” Cancer Research, vol. 69, no. 23, pp. 9065–9072, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. R. Cox, “Regression models and life tables (with discussion),” Journal of Royal Statistical Society: Series B, vol. 34, no. 2, pp. 187–220, 1972. View at Google Scholar
  3. S. Volinia and C. M. Croce, “Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 18, pp. 7413–7417, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-Y. Chen, S.-L. Yu, C.-H. Chen et al., “A five-gene signature and clinical outcome in non-small-cell lung cancer,” The New England Journal of Medicine, vol. 356, no. 1, pp. 11–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Dave, G. Wright, B. Tan et al., “Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells,” New England Journal of Medicine, vol. 351, no. 21, pp. 2159–2169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Li, K. Gao, H. Luo et al., “Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma,” Journal of Experimental and Clinical Cancer Research, vol. 33, no. 1, article 9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-S. Bao, C.-B. Zhang, H.-J. Wang et al., “Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme,” CNS Neuroscience and Therapeutics, vol. 19, no. 9, pp. 714–720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. X.-Q. Zhang, S. Sun, K.-F. Lam et al., “A long non-coding RNA signature in glioblastoma multiforme predicts survival,” Neurobiology of Disease, vol. 58, pp. 123–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Li and J. Gui, “Partial Cox regression analysis for high-dimensional microarray gene expression data,” Bioinformatics, vol. 20, no. 1, pp. i208–i215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Li and H. Li, “Dimension reduction methods for microarrays with applications to censored survival data,” Bioinformatics, vol. 20, no. 18, pp. 3406–3412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. L. Wallace, “Time-dependent tree-structured survival analysis with unbiased variable selection through permutation tests,” Statistics in Medicine, vol. 33, no. 27, pp. 4790–4804, 2014. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  12. A. Kawaguchi, N. Yajima, N. Tsuchiya et al., “Gene expression signature-based prognostic risk score in patients with glioblastoma,” Cancer Science, vol. 104, no. 9, pp. 1205–1210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Gui and H. Li, “Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data,” Bioinformatics, vol. 21, no. 13, pp. 3001–3008, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Evers and C.-M. Messow, “Sparse kernel methods for high-dimensional survival data,” Bioinformatics, vol. 24, no. 14, pp. 1632–1638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Cheng, X. Ren, J. Cai et al., “A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients,” Oncotarget, vol. 6, no. 30, pp. 29285–29295, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Cai, W. Zhang, P. Yang et al., “Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance,” PLoS ONE, vol. 10, no. 5, Article ID 0126022, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Z.-S. Bao, M.-Y. Li, J.-Y. Wang et al., “Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling,” CNS Neuroscience and Therapeutics, vol. 20, no. 2, pp. 112–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Zhang, J. Zhang, W. Yan et al., “Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme,” Cancer, vol. 119, no. 4, pp. 814–824, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Xu, “Bi-linear matrix-variate analyses, integrative hypothesis tests, and case-control studies,” Applied Informatics, vol. 2, no. 1, pp. 1–39, 2015. View at Publisher · View at Google Scholar
  20. I. S. Vlachos, K. Zagganas, M. D. Paraskevopoulou et al., “DIANA-miRPath v3.0: deciphering microRNA function with experimental support,” Nucleic Acids Research, vol. 43, no. 1, pp. W460–W466, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni et al., “DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions,” Nucleic Acids Research, vol. 43, no. 1, pp. D153–D159, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. D. W. Hosmer, S. Lemeshow, and S. May, Applied Suvival Analysis: Regression Modeling of Time-to-Event Data, Wiley-interscience, A John Wiley & Sons, Inc., Hoboken, NJ, USA, 2008. View at MathSciNet
  23. S. Ma and X. Song, “Ranking prognosis markers in cancer genomic studies,” Briefings in Bioinformatics, vol. 12, no. 1, pp. 33–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Dunkler, M. Schemper, and G. Heinze, “Gene selection in microarray survival studies under possibly non-proportional hazards,” Bioinformatics, vol. 26, no. 6, pp. 784–790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. C. Burton, K. R. Lamborn, P. Forsyth et al., “Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors,” Clinical Cancer Research, vol. 8, no. 1, pp. 180–187, 2002. View at Google Scholar · View at Scopus
  26. G. Fulci, M. Labuhn, D. Maier et al., “p53 gene mutation and ink4a-arf-deletion appear to be two mutually exclusive events in human glioblastoma,” Oncogene, vol. 19, no. 33, pp. 3816–3822, 2000. View at Publisher · View at Google Scholar · View at Scopus